The group's principal activity is to provide medical product in bone disorders. The product of the group include Osteoporsis, Fracture Repair, Multiple Myeloma, Bone Marrow, Stem Cell Transplantation, and Renal Bone Disease. The group operates from the United States.
Executive Information
Name
Title
Email
David Krause
Sr. VP, Head - Research & Development, Chief Medical Officer